Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.24 -0.26 (-1.68%)
As of: Nov 11, 2026 · 3:59 PM EST

Ascentage Pharma Group International (AAPG) Finished Goods (2023 - 2025)

Updated

Ascentage Pharma Group International's Finished Goods was $1.06 million in Q4 2025, up 100.7% from $529,042 a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Finished Goods (2023 - 2025) Analysis & Trends

  • In earlier years, Finished Goods was $530,000 in FY2024 (-66.0%) and $1.56 million in FY2023.
  • The Q4 2025 figure marks the highest quarterly Finished Goods since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ascentage Pharma Group International 1.42 Bn 382.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.06 Mn
Dec 31, 2024 529,041.78
Dec 31, 2023 1.56 Mn
API Access

Ascentage Pharma Group International Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=AAPG&period=max&api_key=YOUR_API_KEY